Birdwatch Note
2023-04-19 20:40:42 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This tweet erroneously frames a move by the FDA to no longer authorize the use of MONOVALENT COVID vaccines, specifically. The agency continues to authorize the use of, and recommend, BIVALENT COVID vaccines to prevent illness. https://www.snopes.com/fact-check/fda-covid-monovalent-vaccines/
Written by 4861BD177CB9F94CD687D59EAAAE411FC994C55D6E2DAF5EC661036A618183D5
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1648696595439927305
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1648788735415271427
- noteId - 1648788735415271427
- participantId -
- noteAuthorParticipantId - 4861BD177CB9F94CD687D59EAAAE411FC994C55D6E2DAF5EC661036A618183D5 Participant Details
- createdAtMillis - 1681936842191
- tweetId - 1648696595439927305
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This tweet erroneously frames a move by the FDA to no longer authorize the use of MONOVALENT COVID vaccines, specifically. The agency continues to authorize the use of, and recommend, BIVALENT COVID vaccines to prevent illness. https://www.snopes.com/fact-check/fda-covid-monovalent-vaccines/
Note Ratings
| rated at | rated by | |
| 2023-05-12 02:47:31 -0500 | Rating Details | |
| 2023-04-20 09:27:51 -0500 | Rating Details | |
| 2023-04-22 18:09:59 -0500 | Rating Details | |
| 2023-04-20 13:39:31 -0500 | Rating Details | |
| 2023-04-19 15:52:57 -0500 | Rating Details | |
| 2023-04-19 15:57:56 -0500 | Rating Details | |
| 2023-04-19 17:58:17 -0500 | Rating Details | |
| 2023-04-19 16:23:10 -0500 | Rating Details | |
| 2023-04-19 16:11:52 -0500 | Rating Details | |
| 2023-04-19 15:46:13 -0500 | Rating Details | |
| 2023-04-27 12:08:21 -0500 | Rating Details | |
| 2023-04-19 22:51:37 -0500 | Rating Details | |
| 2023-04-19 16:22:16 -0500 | Rating Details | |
| 2023-04-19 16:02:41 -0500 | Rating Details | |
| 2023-04-19 17:10:02 -0500 | Rating Details | |
| 2023-04-19 16:24:58 -0500 | Rating Details | |
| 2023-04-21 08:22:25 -0500 | Rating Details | |
| 2023-04-20 09:27:51 -0500 | Rating Details | |
| 2023-04-22 18:09:59 -0500 | Rating Details | |
| 2023-04-20 13:39:31 -0500 | Rating Details | |
| 2023-04-19 15:52:57 -0500 | Rating Details | |
| 2023-04-19 15:57:56 -0500 | Rating Details | |
| 2023-04-19 17:58:17 -0500 | Rating Details | |
| 2023-04-19 16:23:10 -0500 | Rating Details | |
| 2023-04-19 16:11:52 -0500 | Rating Details | |
| 2023-04-19 15:46:13 -0500 | Rating Details | |
| 2023-04-27 12:08:21 -0500 | Rating Details | |
| 2023-04-19 22:51:37 -0500 | Rating Details | |
| 2023-04-19 16:22:16 -0500 | Rating Details | |
| 2023-05-12 02:47:31 -0500 | Rating Details | |
| 2023-04-19 16:02:41 -0500 | Rating Details | |
| 2023-04-19 17:10:02 -0500 | Rating Details | |
| 2023-04-19 16:24:58 -0500 | Rating Details | |
| 2023-04-21 08:22:25 -0500 | Rating Details |